Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3339 | 2004 | 32.7 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
296 | 3 | BREAST//BREAST CANCER//LYMPHEDEMA | 41323 |
994 | 2 | BREAST CANCER//BREAST CONSERVING THERAPY//BREAST CONSERVING SURGERY | 10470 |
3339 | 1 | NEOADJUVANT CHEMOTHERAPY//LOCALLY ADVANCED BREAST CANCER//PATHOLOGIC COMPLETE RESPONSE | 2004 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NEOADJUVANT CHEMOTHERAPY | authKW | 2008028 | 28% | 23% | 565 |
2 | LOCALLY ADVANCED BREAST CANCER | authKW | 868587 | 6% | 51% | 112 |
3 | PATHOLOGIC COMPLETE RESPONSE | authKW | 490483 | 4% | 45% | 72 |
4 | PATHOLOGICAL COMPLETE RESPONSE | authKW | 447673 | 3% | 43% | 69 |
5 | PRIMARY CHEMOTHERAPY | authKW | 343370 | 2% | 48% | 47 |
6 | NEOADJUVANT | authKW | 321161 | 7% | 16% | 132 |
7 | PRIMARY SYSTEMIC THERAPY | authKW | 311495 | 2% | 66% | 31 |
8 | NEOADJUVANT THERAPY | authKW | 210631 | 6% | 11% | 125 |
9 | BREAST CANCER | authKW | 180824 | 40% | 1% | 809 |
10 | NEOADJUVANT ENDOCRINE THERAPY | authKW | 171859 | 1% | 59% | 19 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 45568 | 77% | 0% | 1534 |
2 | Radiology, Nuclear Medicine & Medical Imaging | 1597 | 12% | 0% | 240 |
3 | Obstetrics & Gynecology | 1257 | 8% | 0% | 166 |
4 | Surgery | 1037 | 14% | 0% | 282 |
5 | Pathology | 108 | 3% | 0% | 56 |
6 | Medicine, General & Internal | 11 | 3% | 0% | 59 |
7 | Medicine, Research & Experimental | 5 | 2% | 0% | 38 |
8 | Medical Laboratory Technology | -0 | 0% | 0% | 4 |
9 | Primary Health Care | -0 | 0% | 0% | 1 |
10 | Health Care Sciences & Services | -1 | 0% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BREAST MED ONCOL | 119132 | 5% | 8% | 104 |
2 | GERMAN BREAST GRP | 77437 | 1% | 27% | 19 |
3 | EDINBURGH BREAST UNIT | 68094 | 1% | 17% | 27 |
4 | BUR RECH CLIN | 67862 | 0% | 64% | 7 |
5 | BREAST SURG | 59864 | 6% | 4% | 112 |
6 | SENOL | 57349 | 2% | 9% | 41 |
7 | BREAST UNIT | 56508 | 3% | 6% | 64 |
8 | UNIT MED SENOL | 55693 | 1% | 23% | 16 |
9 | B2T | 47607 | 0% | 63% | 5 |
10 | BREAST ONCOL | 46397 | 2% | 6% | 47 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLINICAL BREAST CANCER | 36647 | 2% | 6% | 43 |
2 | BREAST CANCER | 35242 | 2% | 6% | 38 |
3 | BREAST CANCER RESEARCH AND TREATMENT | 34945 | 6% | 2% | 129 |
4 | BREAST | 24927 | 3% | 3% | 63 |
5 | ANNALS OF SURGICAL ONCOLOGY | 13628 | 4% | 1% | 80 |
6 | ANNALS OF ONCOLOGY | 10895 | 4% | 1% | 77 |
7 | BREAST JOURNAL | 10576 | 1% | 3% | 27 |
8 | JOURNAL OF BREAST CANCER | 9698 | 1% | 3% | 19 |
9 | JOURNAL OF CLINICAL ONCOLOGY | 6376 | 4% | 1% | 83 |
10 | BREAST CARE | 5985 | 1% | 3% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEOADJUVANT CHEMOTHERAPY | 2008028 | 28% | 23% | 565 | Search NEOADJUVANT+CHEMOTHERAPY | Search NEOADJUVANT+CHEMOTHERAPY |
2 | LOCALLY ADVANCED BREAST CANCER | 868587 | 6% | 51% | 112 | Search LOCALLY+ADVANCED+BREAST+CANCER | Search LOCALLY+ADVANCED+BREAST+CANCER |
3 | PATHOLOGIC COMPLETE RESPONSE | 490483 | 4% | 45% | 72 | Search PATHOLOGIC+COMPLETE+RESPONSE | Search PATHOLOGIC+COMPLETE+RESPONSE |
4 | PATHOLOGICAL COMPLETE RESPONSE | 447673 | 3% | 43% | 69 | Search PATHOLOGICAL+COMPLETE+RESPONSE | Search PATHOLOGICAL+COMPLETE+RESPONSE |
5 | PRIMARY CHEMOTHERAPY | 343370 | 2% | 48% | 47 | Search PRIMARY+CHEMOTHERAPY | Search PRIMARY+CHEMOTHERAPY |
6 | NEOADJUVANT | 321161 | 7% | 16% | 132 | Search NEOADJUVANT | Search NEOADJUVANT |
7 | PRIMARY SYSTEMIC THERAPY | 311495 | 2% | 66% | 31 | Search PRIMARY+SYSTEMIC+THERAPY | Search PRIMARY+SYSTEMIC+THERAPY |
8 | NEOADJUVANT THERAPY | 210631 | 6% | 11% | 125 | Search NEOADJUVANT+THERAPY | Search NEOADJUVANT+THERAPY |
9 | BREAST CANCER | 180824 | 40% | 1% | 809 | Search BREAST+CANCER | Search BREAST+CANCER |
10 | NEOADJUVANT ENDOCRINE THERAPY | 171859 | 1% | 59% | 19 | Search NEOADJUVANT+ENDOCRINE+THERAPY | Search NEOADJUVANT+ENDOCRINE+THERAPY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CEUGNART, L , COUDERT, B , DALENC, F , GUINEBRETIERE, JM , ROUANET, P , TOLEDANO, A , (2011) THE NEOADJUVANT TREATMENT (EXCLUDING INFLAMMATORY BREAST CANCER).ONCOLOGIE. VOL. 13. ISSUE 10-11. P. 658-680 | 110 | 75% | 0 |
2 | PINDER, SE , RAKHA, EA , PURDIE, CA , BARTLETT, JMS , FRANCIS, A , STEIN, RC , THOMPSON, AM , SHAABAN, AM , (2015) MACROSCOPIC HANDLING AND REPORTING OF BREAST CANCER SPECIMENS PRE- AND POST-NEOADJUVANT CHEMOTHERAPY TREATMENT: REVIEW OF PATHOLOGICAL ISSUES AND SUGGESTED APPROACHES.HISTOPATHOLOGY. VOL. 67. ISSUE 3. P. 279 -293 | 65 | 76% | 2 |
3 | MAKHOUL, I , KIWAN, E , (2011) NEOADJUVANT SYSTEMIC TREATMENT OF BREAST CANCER.JOURNAL OF SURGICAL ONCOLOGY. VOL. 103. ISSUE 4. P. 348 -357 | 67 | 78% | 13 |
4 | MARINOVICH, ML , HOUSSAMI, N , MACASKILL, P , SARDANELLI, F , IRWIG, L , MAMOUNAS, EP , VON MINCKWITZ, G , BRENNAN, ME , CIATTO, S , (2013) META-ANALYSIS OF MAGNETIC RESONANCE IMAGING IN DETECTING RESIDUAL BREAST CANCER AFTER NEOADJUVANT THERAPY.JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. VOL. 105. ISSUE 5. P. 321-333 | 48 | 80% | 48 |
5 | PROVENZANO, E , BOSSUYT, V , VIALE, G , CAMERON, D , BADVE, S , DENKERT, C , MACGROGAN, G , PENAULT-LLORCA, F , BOUGHEY, J , CURIGLIANO, G , ET AL (2015) STANDARDIZATION OF PATHOLOGIC EVALUATION AND REPORTING OF POSTNEOADJUVANT SPECIMENS IN CLINICAL TRIALS OF BREAST CANCER: RECOMMENDATIONS FROM AN INTERNATIONAL WORKING GROUP.MODERN PATHOLOGY. VOL. 28. ISSUE 9. P. 1185 -1201 | 49 | 83% | 6 |
6 | VON MINCKWITZ, G , UNTCH, M , BLOHMER, JU , COSTA, SD , EIDTMANN, H , FASCHING, PA , GERBER, B , EIERMANN, W , HILFRICH, J , HUOBER, J , ET AL (2012) DEFINITION AND IMPACT OF PATHOLOGIC COMPLETE RESPONSE ON PROGNOSIS AFTER NEOADJUVANT CHEMOTHERAPY IN VARIOUS INTRINSIC BREAST CANCER SUBTYPES.JOURNAL OF CLINICAL ONCOLOGY. VOL. 30. ISSUE 15. P. 1796-1804 | 25 | 78% | 416 |
7 | SALMON, R , CEUGNART, L , SELZ, J , HENNEQUIN, C , ETTORE, F , GONCALVES, A , (2013) TNA NEOADJUVANT TREATMENTS (RPC 2013).ONCOLOGIE. VOL. 15. ISSUE 12. P. 607-636 | 78 | 52% | 2 |
8 | CORTAZAR, P , ZHANG, LJ , UNTCH, M , MEHTA, K , COSTANTINO, JP , WOLMARK, N , BONNEFOI, H , CAMERON, D , GIANNI, L , VALAGUSSA, P , ET AL (2014) PATHOLOGICAL COMPLETE RESPONSE AND LONG-TERM CLINICAL BENEFIT IN BREAST CANCER: THE CTNEOBC POOLED ANALYSIS.LANCET. VOL. 384. ISSUE 9938. P. 164 -172 | 18 | 82% | 328 |
9 | BERRUTI, A , AMOROSO, V , GALLO, F , BERTAGLIA, V , SIMONCINI, E , PEDERSINI, R , FERRARI, L , BOTTINI, A , BRUZZI, P , SORMANI, MP , (2014) PATHOLOGIC COMPLETE RESPONSE AS A POTENTIAL SURROGATE FOR THE CLINICAL OUTCOME IN PATIENTS WITH BREAST CANCER AFTER NEOADJUVANT THERAPY: A META-REGRESSION OF 29 RANDOMIZED PROSPECTIVE STUDIES.JOURNAL OF CLINICAL ONCOLOGY. VOL. 32. ISSUE 34. P. 3883 -U288 | 35 | 80% | 49 |
10 | MATHEW, J , ASGEIRSSON, KS , CHEUNG, KL , CHAN, S , DAHDA, A , ROBERTSON, JFR , (2009) NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER: A REVIEW OF THE LITERATURE AND FUTURE DIRECTIONS.EJSO. VOL. 35. ISSUE 2. P. 113-122 | 47 | 82% | 35 |
Classes with closest relation at Level 1 |